Clinical Trial Update: Kawasaki Disease During the COVID-19 Epidemic

View source ↗

Summary

Clinical trial investigating Kawasaki Disease conducted during the COVID-19 epidemic has completed. Sponsor: IRCCS Burlo Garofolo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Snippet

Sponsor: IRCCS Burlo Garofolo | Conditions: Kawasaki Disease | Status: COMPLETED